Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Decline in Short Interest

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totaling 23,021 shares, a drop of 51.0% from the June 30th total of 46,964 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average trading volume of 97,056 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

SAUHY has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a research note on Tuesday, June 30th. BMO Capital Markets began coverage on shares of Straumann in a report on Wednesday, July 8th. They set an “outperform” rating on the stock. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research note on Thursday, July 9th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Finally, Barclays restated an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Straumann currently has an average rating of “Hold”.

Straumann Trading Up 4.8%

Shares of SAUHY stock opened at $12.32 on Wednesday. Straumann has a 12 month low of $9.44 and a 12 month high of $13.73. The business’s 50 day moving average is $12.31 and its two-hundred day moving average is $11.68.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.